asparaginase

Type: Keyphrase
Name: asparaginase
First reported 11 hours ago - Updated 11 hours ago - 1 reports

Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014

Interested parties may access the live audio webcast via the Investors & Media section of the Jazz Pharmaceuticals website at www.jazzpharmaceuticals.com. Please connect to the website prior to the start of the conference call to ensure adequate time ... [Published Pettinga Financial Advisors - 11 hours ago]
First reported Oct 20 2014 - Updated 21 hours ago - 4 reports

ERYTECH PHARMA : wins EuropaBio’s Most Innovative European Biotech SME Award 2014

PRESS RELEASE ERYTECH wins EuropaBio's Most Innovative European Biotech SME Award 2014Lyon (France), October 9, 2014 - ERYTECH (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments ... [Published 4 Traders - 21 hours ago]
First reported Oct 09 2014 - Updated Oct 09 2014 - 1 reports

ERYTECH wins EuropaBio's Most Innovative European Biotech SME Award 2014

--Regulatory News:ERYTECH (Paris:ERYP)(Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia and other oncology indications with unmet medical needs, won EuropaBio's ... [Published Scottrade - Oct 09 2014]
First reported Oct 07 2014 - Updated Oct 08 2014 - 1 reports

Test for predicting neutralization of asparaginase activity

Method of in vitro measurement of the presence of factors that are able to neutralize asparaginase activity in a sample of blood, plasma, serum or derived medium that may contain asparaginase neutralizing factors, obtained from a patient, comprising mixing ... [Published Free Patents Online - Oct 07 2014]
First reported Oct 02 2014 - Updated Oct 02 2014 - 1 reports

Karolinska Development's CEO leaves, Erytech hits PhIII endpoints, VBL belatedly nails IPO

Welcome to the latest edition of our weekly EuroBiotech Report . The CEO of Karolinska Development ( STO:KDEV ) left the company--9 months after the CFO departed--and the board began a rethink of its strategy. VBL Therapeutics ( $VBLX ) made a belated ... [Published FierceBiotech - Oct 02 2014]
First reported Sep 30 2014 - Updated Oct 01 2014 - 2 reports

Erytech reports positive Phase III results from Graspa study in acute lymphoblastic leukemia

French firm Erytech Pharma (Euronext: ERYP) and Italian drugmaker Recordati (RC: MI) have reported positive Phase III results from its study of Graspa in acute lymphoblastic leukemia.Compared to native L-asparaginase, Graspa gave statistically significant ... [Published Pharma Letter - Oct 01 2014]
First reported Sep 22 2014 - Updated Sep 22 2014 - 1 reports

Understanding Digestive Enzymes

Enzyme ingredients step in to help provide a greater variety of safe and nutritious foods for consumers.By Claudia O’Donnell, Contributing EditorSep 22, 2014Quiz question: What do the dietary supplement Beano, Horizon Organic Lactose-Free milks, Shiloh ... [Published FoodProcessing.com - Sep 22 2014]
Entities: Lactase, Enzyme, Acrylamide
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Long live peptides evolution of peptide half-life extension technologies and emerging hybrid approaches. Spring 14

Among therapeutic modalities, peptides occupy a middle ground between traditional ‘small molecule’ drugs and the larger injectable biologics, not fitting comfortably into either category.P eptides, particularly those based on endogenous human hormones, ... [Published Drug Discovery World - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

Caring for a Child With Leukemia

at 9:14 am , by Kara CorridanWe continue to bring attention to month with another story from a parent who has been affected. (Last week we featured a post from Stefani Healey, the mother of Brooke, who died of a rare form of brain cancer last September.) ... [Published Parents.com - Sep 15 2014]
First reported Sep 15 2014 - Updated Sep 15 2014 - 1 reports

ERYTECH Announces Second Positive DSMB Review of Its Phase IIb Study in Acute Myeloid Leukemia

By a News Reporter-Staff News Editor at Clinical Trials Week Regulatory News: ERYTECH Pharma (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative 'tumor starvation' treatments for acute leukemia ... [Published Pharmacy Choice - Sep 15 2014]
First reported May 20 2014 - Updated May 20 2014 - 1 reports

Research and Markets: Baking Enzymes Market 2014-2019: Types & Applications Trends & Forecasts

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their ... [Published Business Wire Retail News - May 20 2014]
First reported May 07 2014 - Updated May 07 2014 - 1 reports

Erytech receives ANSM authorisation to begin phase II study in pancreatic cancer

Erytech Pharma, a French bio-pharmaceutical company that develops innovative treatments for acute leukaemia and other oncology indications with unmet medical needs, announces that the French healthcare agency, ANSM has granted the authorisation to start ... [Published PharmaBiz - May 07 2014]

Quotes

"We are very proud to receive this award. It is a recognition for all employees of ERYTECH and our many partners, without whom we would not have come to this stage. All of us share one mission: to develop innovative tumor starvation treatments for cancer patients, particularly those with acute leukemia and selected solid tumors . " said Pierre-Olivier Goineau, COO and co-founder of ERYTECH together with Yann Godfrin, inventor of the technology
"We are very pleased and encouraged by the positive results of this Phase III study. They validate the potential of our red cell bioreactor technology platform to increase the therapeutic index and tolerability of certain drugs. With GRASPA™, the enzyme activity is protected by the red cell membrane, preventing neutralisation by circulating antibodies. I wish to take this opportunity to thank all people who contributed to this study, patients, physicians and the Erytech team and collaborators, for their efforts and dedication." , said Yann Godfrin, co-founder and Chief Scientific Officer of ERYTECH Pharma
...This analysis is anticipated towards the end of this year. "We are pleased to see that this second DSMB review confirmed the safety profile of the product. This is all the more important as this is the first time that a large group of elderly AML patients is receiving repeated doses of an asparaginase-based product in a controlled clinical trial. The use of asparaginase has to date been very limited in this indication due to the toxicity of the current forms of asparaginase. Thanks to the encapsulation in the red blood cells we are enabling the use of asparaginase in the treatment of these very fragile patients" , comments Yann Godfrin, co-founder and CSO of ERYTECH Pharma. About ERYTECH and ERY-ASP/GRASPA: www.erytech...
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their offering. The global baking industry is fast inculcating the use of enzymes in light of the numerous advantages they present...

More Content

All (23) | News (19) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (2)
sort by: Date | Relevance
Jazz Pharmaceuticals to Report 2014 Third Quart... [Published Pettinga Financial Advisors - 11 hours ago]
ERYTECH PHARMA : wins EuropaBio’s Most Innovati... [Published 4 Traders - 21 hours ago]
DGAP-News: ERYTECH PHARMA SA: ERYTECH announces... [Published GlobeNewswire: Acquisitions News - 22 hours ago]
BRIEF-Erytech Pharma gets new patent in U.S. in... [Published Reuters UK - Oct 20 2014]
ERYtech Pharma Announces Granting Of New Patent... [Published BioSpace - Oct 20 2014]
ERYTECH Announces Granting of New Patent in the... [Published Business Wire Health News - Oct 20 2014]
ERYTECH wins EuropaBio's Most Innovative Europe... [Published Scottrade - Oct 09 2014]
Test for predicting neutralization of asparagin... [Published Free Patents Online - Oct 07 2014]
Karolinska Development's CEO leaves, Erytech hi... [Published FierceBiotech - Oct 02 2014]
Erytech reports positive Phase III results from... [Published Pharma Letter - Oct 01 2014]
ERYTECH Reports Positive Top-Line Phase III Res... [Published BusinessWeek - Sep 30 2014]
Understanding Digestive Enzymes [Published FoodProcessing.com - Sep 22 2014]
Long live peptides evolution of peptide half-li... [Published Drug Discovery World - Sep 15 2014]
Caring for a Child With Leukemia [Published Parents.com - Sep 15 2014]
ERYTECH Announces Second Positive DSMB Review o... [Published Pharmacy Choice - Sep 15 2014]
MicroRNA-140-5p as a tumor suppressor and sensi... [Published PharmCast - Jul 18 2014]
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
Compositions and methods for delivering inhibit... [Published PharmCast - May 08 2014]
Erytech receives ANSM authorisation to begin ph... [Published PharmaBiz - May 07 2014]
Tumor-initiating cells and methods of use [Published PharmCast - Apr 09 2014]
Delivery system for cytotoxic drugs by bispecif... [Published PharmCast - Mar 02 2014]
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
Methods and compositions for targeting agents i... [Published PharmCast - Jan 05 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
ERYTECH Announces Granting of New Patent in the... [Published Business Wire Health News - Oct 20 2014]
LYON, France--(BUSINESS WIRE)--Regulatory News : ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications ...
Research and Markets: Baking Enzymes Market 201... [Published Business Wire Retail News - May 20 2014]
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/8tqx89/baking_enzymes) has announced the addition of the "Baking Enzymes Market by Geography, Types & Application- Global Trends & Forecasts to 2019" report to their ...
1

Press Releases

sort by: Date | Relevance
DGAP-News: ERYTECH PHARMA SA: ERYTECH announces... [Published GlobeNewswire: Acquisitions News - 22 hours ago]
Jazz Pharmaceuticals Announces Acquisition From... [Published PR Newswire - Jan 13 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.